Search

Displaying results 2711 - 2720 of 10000 in total
  1. Drug

    Metamfazone

    go.drugbank.com/drugs/DB20145
    Experimental

    Metamfazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Metamfazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  2. Drug

    Depramine

    go.drugbank.com/drugs/DB20198
    Experimental

    Depramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Depramine is a substance of the imipramine group.

  3. Drug

    Ramorelix

    go.drugbank.com/drugs/DB20209
    Experimental

    Ramorelix is a small molecule drug. The usage of the INN stem '-relix' in the name indicates that Ramorelix is a gonadotropin-releasing-hormone (GnRH) inhibitor.

  4. Drug

    Ftaxilide

    go.drugbank.com/drugs/DB20254
    Experimental

    Ftaxilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ftaxilide is a sematilide derivative class III antiarrhythmic.

  5. Drug

    Ipenoxazone

    go.drugbank.com/drugs/DB20277
    Experimental

    Ipenoxazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Ipenoxazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  6. Drug

    Pirbenicillin

    go.drugbank.com/drugs/DB20321
    Experimental

    Pirbenicillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Pirbenicillin is a antibiotic, 6-aminopenicillanic acid derivative.

  7. Drug

    Bisphenol A diglycidyl ether

    go.drugbank.com/drugs/DB14083
    Approved

    Mixtures: Test Thin-Layer Rapid Use Patch Test
  8. Drug

    Dipentamethylenethiuram disulfide

    go.drugbank.com/drugs/DB14174
    Approved

    Mixtures: Test Thin-Layer Rapid Use Patch Test
  9. Drug

    N,N'-diphenyl-1,4-phenylenediamine

    go.drugbank.com/drugs/DB14192
    Approved

    Mixtures: Test Thin-Layer Rapid Use Patch Test
  10. Drug

    renizgamglogene autogedtemcel

    go.drugbank.com/drugs/DB25530
    Investigational

    renizgamglogene autogedtemcel is a biologic drug. renizgamglogene autogedtemcel is under investigation in clinical trial NCT05444894 (EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in

    Synonyms: Autologous CD34+ hematopoietic stem and progenitor cells edited by CRISPR/CAS12a at the HBG1 and HBG2 promoters, autologous CD34+ hematopoietic stem and progenitor cells edited by CRISPR/Cas12a ribonucleoprotein (RNP) at the HBG1 and HBG2 promoters